跳至内容
Advertisement

对肥胖症药物覆盖范围的限制迫使患者转向

去年,有 1200 万人失去了 Zepbound 的保险。根据药品折扣网站 GoodRx 的分析,同样数量的人失去了 Wegovy 的保险。

schedule 13:25 visibility 54 浏览
对肥胖症药物覆盖范围的限制迫使患者转向
来源: NPR News
Meghan Lena was devastated when she lost coverage for her obesity medication.

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

(Image credit: Jodi Hilton for NPR)

newspaper

原文发布于

NPR News

open_in_new 阅读全文